What is the characteristic feature of diabetic (Dm) scleredema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Scleredema: Characteristic Features

The characteristic feature of diabetic scleredema (scleredema diabeticorum) is the accumulation of mucopolysaccharides in the skin. This condition represents a rare metabolic connective tissue manifestation of diabetes mellitus, particularly type 2 diabetes.

Pathophysiological Features

  • Histopathological findings: Scleredema diabeticorum is characterized by dermal thickening with mucopolysaccharide deposits between widened collagen fibers 1, 2
  • Clinical presentation: The condition manifests as thickened, stiffened, and leathery skin with a peau d'orange appearance 3
  • Distribution: Commonly affects the posterior aspect of the neck, upper back, and chest wall 3, 4

Distinguishing Features from Other Conditions

Scleredema diabeticorum must be differentiated from other similar conditions:

  • Scleredema: Characterized by dermal sclerosis with collagen bundle thickening 1
  • Scleromyxedema: Characterized by increased fibroblasts and mucin deposition 1
  • Eosinophilic fasciitis: Distinguished by thickened fascia with inflammatory infiltrate 1

Clinical Implications

  • Respiratory effects: Extensive chest wall involvement can lead to external restrictive lung disease and hypoventilation due to limited chest wall movement 3
  • Mobility limitations: Can cause decreased motility of the shoulders 2
  • Associated complications: Patients with scleredema diabeticorum may have a higher incidence of angina pectoris compared to diabetic patients without scleredema 5

Patient Demographics and Risk Factors

  • Gender predilection: More common in male patients 6, 3
  • Diabetes control: Associated with poorly controlled, long-term diabetes mellitus 6, 3
  • Comorbidities: Often seen in patients with obesity and established diabetic microvascular complications 3
  • Prevalence: Estimated to affect approximately 2.5% of diabetic patients 5

Management Considerations

  • Phototherapy: UVA1 or PUVA therapy has shown the highest, although partial, response rates 6
  • Systemic treatments: Corticosteroids and immunosuppressive drugs are reserved for severe cases where phototherapy has failed 6
  • Diabetes management: Strict glycemic control combined with physical therapy is recommended 6

Diabetic scleredema is a chronic condition that, while not necessarily life-threatening, can significantly impact quality of life through skin thickening and potential respiratory complications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.